More Globe Newswire

View Older Stories View Newer Stories

Mar 11, 2024 07:06AM Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
Mar 11, 2024 07:05AM Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
Mar 11, 2024 07:05AM Manhattan Bridge Capital, Inc. Reports Results for 2023
Mar 11, 2024 07:04AM Dimensional Fund Advisors Ltd. : Form 8.3 - Direct Line Insurance Group plc - Ordinary Shares
Mar 11, 2024 07:05AM Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
Mar 11, 2024 07:02AM Dimensional Fund Advisors Ltd. : Form 8.3 - CUSTODIAN PROPERTY INCOME RE - Ordinary Shares
Mar 11, 2024 07:00AM Microbix Unveils Test Controls for Head and Neck Cancer
Mar 11, 2024 07:00AM Corporate Update: Meni Morim to Step Down as CEO
Mar 11, 2024 07:00AM Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
Mar 11, 2024 07:00AM Clarus Files Lawsuit Against Caption Management LLC, Caption Partners II LP, Caption GP, LLC, William Cooper and Jason Strasser for Recovery of Short-Swing Profits
Mar 11, 2024 07:00AM Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
Mar 11, 2024 07:00AM Abaxx Prepares Exchange Opening Sequence and Final Notices
Mar 11, 2024 07:00AM Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division
Mar 11, 2024 07:00AM Cielo Announces Closing of First Tranche of Private Placement of Convertible Debenture Units
Mar 11, 2024 07:00AM Emerita Intersects 68.9 Meters Grading 0.7% Copper; 0.3% Lead; 0.5% Zinc, 0.91 g/t Gold and 36.2 g/t Silver, Including 9.4 Meters Grading 0.9% Copper; 0.3% Lead; 1.4% Zinc, 1.59 g/t Gold and 37.8 g/t
Mar 11, 2024 07:00AM Pulsar Helium Special Virtual Conference Today Register Now
Mar 11, 2024 07:00AM Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases
Mar 11, 2024 07:00AM Lantronix to Participate in 36th Annual Roth Conference Held March 17–19, 2024
Mar 11, 2024 07:00AM Monte Rosa Therapeutics Announces Initiation of IND Enabling Studies for MRT-8102, A First-in-Class NEK7 Directed Molecular Glue Degrader and NLRP3/IL-1β Pathway Inhibitor
Mar 11, 2024 07:00AM Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor Event
Mar 11, 2024 07:00AM Plymouth Industrial REIT Development Projects in Jacksonville Earn Green Globes® Certification for Core & Shell Construction
Mar 11, 2024 07:00AM ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
Mar 11, 2024 07:00AM FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
Mar 11, 2024 07:00AM Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA
Mar 11, 2024 07:00AM Arvig to Invest Grant Funding in $5 Million Fiber Expansion for 3 Minnesota Counties
Mar 11, 2024 07:00AM mdf commerce enters definitive agreement to be acquired by KKR
Mar 11, 2024 07:00AM ASLAN Pharmaceuticals Provides TREK-DX Study Update and Highlights Potential of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
Mar 11, 2024 07:00AM Tower Semiconductor to Present at 2024 SEMICON China Addressing Advanced CMOS Process Technology for Micro Displays
Mar 11, 2024 07:00AM Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation
Mar 11, 2024 07:00AM Smart Share Global Limited Declares a Special Cash Dividend
Mar 11, 2024 07:00AM Tecnoglass to Present at the Sidoti Virtual Small Cap Conference
Mar 11, 2024 07:00AM Autolus Therapeutics announces publication in Blood Cancer Journal
Mar 11, 2024 07:00AM Akoustis to Attend the 36th Annual Roth Conference on March 17-19, 2024
Mar 11, 2024 07:00AM Amplify Energy Update on Southern California Oil Sheen
Mar 11, 2024 07:00AM ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio
Mar 11, 2024 07:00AM Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
Mar 11, 2024 07:00AM Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
Mar 11, 2024 07:00AM ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
Mar 11, 2024 07:00AM Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
Mar 11, 2024 07:00AM Senior Business Leader Joins SMU Cox Spears Institute for Entrepreneurial Leadership
Mar 11, 2024 07:00AM CareCloud to Showcase its Generative AI Solutions and Tech-Enabled RCM at the 2024 HIMSS Conference and Exhibition
Mar 11, 2024 07:00AM Ceco Environmental to Participate in the 36th Annual Roth Conference on March 18
Mar 11, 2024 07:00AM Cory Gitt Joins BridgeCore Capital as Managing Director, Loan Originations
Mar 11, 2024 07:00AM DISQO’s Cross-Media Ad Measurement Now Amplified By Inscape’s Smart TV Viewing Data
Mar 11, 2024 07:00AM Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th
Mar 11, 2024 07:00AM AIChE and IChemE Announce Webinar Series and Annual Conference to Advance Hydrogen as an Energy Carrier
Mar 11, 2024 07:00AM CivicLab Appoints Newest Fellow
Mar 11, 2024 07:00AM Resonant Link Demonstrates Automated Wireless Charging at MODEX
Mar 11, 2024 07:00AM Replay’s cell therapy product company Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy for multiple myeloma
Mar 11, 2024 06:59AM Rego Payment Architectures, Inc. Launches Accessibility Features for the Visually Impaired
View Newer Stories View Older Stories